Skip to main content
. Author manuscript; available in PMC: 2020 Dec 11.
Published in final edited form as: Cortex. 2018 Jul 31;108:67–79. doi: 10.1016/j.cortex.2018.07.014

Table 1.

Participant Characteristics and Medication Information

Group N CA in years (SD) MA in years (SD) N on Medication
22q11DS 15 (7 female) 20.74 (2.5) 17.02 (3.5) 6a
CA matched 15 (9 female) 20.86 (2.36) - 0
MA matched 15 (12 female) 17.06 (3.71) - 0

Notes. CA = chronological age, MA = mental age, SE = standard error of measurement

a

Indicates the number of participants that were taking one or more medications (stimulants, benzodiazepines, anti-depressants or anti-anxiety) to manage symptoms associated with 22q11DS during their participation in the study.